ArticleJournal of hematology & oncology2021

PSEN1-selective gamma-secretase inhibition in combination with kinase or XPO-1 inhibitors effectively targets T cell acute lymphoblastic leukemia.

Inge Govaerts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.